136 related articles for article (PubMed ID: 9195372)
21. Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.
Di Pascoli M; Diví M; Rodríguez-Vilarrupla A; Rosado E; Gracia-Sancho J; Vilaseca M; Bosch J; García-Pagán JC
J Hepatol; 2013 May; 58(5):904-10. PubMed ID: 23262250
[TBL] [Abstract][Full Text] [Related]
22. [Effects of ET-1 on isolated perfused rat liver and vascular rings at two stages of cirrhosis].
Yao D; Yao X; Yang C; Feng Z; Fang H; Gao J
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1565-8. PubMed ID: 12609069
[TBL] [Abstract][Full Text] [Related]
23. Portal vascular responsiveness to sympathetic stimulation and nitric oxide in cirrhotic rats.
Mathie RT; Ralevic V; Burnstock G
J Hepatol; 1996 Jul; 25(1):90-7. PubMed ID: 8836907
[TBL] [Abstract][Full Text] [Related]
24. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
Reiberger T; Payer BA; Schwabl P; Hayden H; Horvatits T; Jäger B; Hummel T; Mitterhauser M; Trauner M; Fuhrmann V; Angermayr B; Peck-Radosavljevic M;
Liver Int; 2013 Apr; 33(4):561-8. PubMed ID: 23331709
[TBL] [Abstract][Full Text] [Related]
25. The effect of endothelin and its antagonist Bosentan on hemodynamics and microvascular exchange in cirrhotic rat liver.
Reichen J; Gerbes AL; Steiner MJ; Sägesser H; Clozel M
J Hepatol; 1998 Jun; 28(6):1020-30. PubMed ID: 9672179
[TBL] [Abstract][Full Text] [Related]
26. High-frequency vagus nerve stimulation improves portal hypertension in cirrhotic rats.
Bockx I; Verdrengh K; Vander Elst I; van Pelt J; Nevens F; Laleman W; Cassiman D
Gut; 2012 Apr; 61(4):604-12. PubMed ID: 22187073
[TBL] [Abstract][Full Text] [Related]
27. In vivo gene transfer of endothelial nitric oxide synthase decreases portal pressure in anaesthetised carbon tetrachloride cirrhotic rats.
Van de Casteele M; Omasta A; Janssens S; Roskams T; Desmet V; Nevens F; Fevery J
Gut; 2002 Sep; 51(3):440-5. PubMed ID: 12171971
[TBL] [Abstract][Full Text] [Related]
28. Propranolol decreases portal pressure without changing portocollateral resistance in cirrhotic rats.
Pizcueta MP; de Lacy AM; Kravetz D; Bosch J; Rodés J
Hepatology; 1989 Dec; 10(6):953-7. PubMed ID: 2583690
[TBL] [Abstract][Full Text] [Related]
29. Chronic blockade of endothelin receptors in cirrhotic rats: hepatic and hemodynamic effects.
Poo JL; Jiménez W; María Muñoz R; Bosch-Marcé M; Bordas N; Morales-Ruiz M; Pérez M; Deulofeu R; Solé M; Arroyo V; Rodés J
Gastroenterology; 1999 Jan; 116(1):161-7. PubMed ID: 9869614
[TBL] [Abstract][Full Text] [Related]
30. Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension.
Laviña B; Gracia-Sancho J; Rodríguez-Vilarrupla A; Chu Y; Heistad DD; Bosch J; García-Pagán JC
Gut; 2009 Jan; 58(1):118-25. PubMed ID: 18829979
[TBL] [Abstract][Full Text] [Related]
31. The effects of vasopressin on hepatic haemodynamics in the cirrhotic and non-cirrhotic rat.
Jenkins SA; Day DW; Mooney B; Devitt P; Baxter JN; Taylor I; Shields R
Langenbecks Arch Chir; 1985; 365(2):135-46. PubMed ID: 4046683
[TBL] [Abstract][Full Text] [Related]
32. [Influence of platelet activating factor and its antagonist on portal hypertension associated with liver cirrhosis: an experiment with rats].
Wang CP; Han J; Ma XM; Dong K; Xiang Y; Su SH; Feng YY; Yang YP
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3337-41. PubMed ID: 16409839
[TBL] [Abstract][Full Text] [Related]
33. Intraportal administration of glyceryl trinitrate or nitroprusside exerts more systemic than intrahepatic effects in anaesthetised cirrhotic rats.
Van de Casteele M; Hösli M; Sägesser H; Reichen J
J Hepatol; 1999 Aug; 31(2):300-5. PubMed ID: 10453944
[TBL] [Abstract][Full Text] [Related]
34. On the pathogenesis of portal hypertension in cirrhosis of the liver.
Shibayama Y
Liver; 1988 Apr; 8(2):95-9. PubMed ID: 3367713
[TBL] [Abstract][Full Text] [Related]
35. Improvement of portal hypertension and hepatic blood flow in cirrhotic rats by oestrogen.
Sakamoto M; Ueno T; Nakamura T; Sakata R; Hasimoto O; Torimura T; Sata M
Eur J Clin Invest; 2005 Mar; 35(3):220-5. PubMed ID: 15733078
[TBL] [Abstract][Full Text] [Related]
36. An endothelin receptor antagonist TAK-044 ameliorates carbon tetrachloride-induced acute liver injury and portal hypertension in rats.
Gandhi CR; Nemoto EM; Watkins SC; Subbotin VM
Liver; 1998 Feb; 18(1):39-48. PubMed ID: 9548266
[TBL] [Abstract][Full Text] [Related]
37. Endothelin-1 selectively contracts portal vein through both ETA and ETB receptors in isolated rabbit liver.
Wang HG; Shibamoto T; Miyahara T
Am J Physiol; 1997 Nov; 273(5):G1036-43. PubMed ID: 9374700
[TBL] [Abstract][Full Text] [Related]
38. Glycyrrhizinate reduces portal hypertension in isolated perfused rat livers with chronic hepatitis.
Zhao X; Deng B; Xu XY; Yang SJ; Zhang T; Song YJ; Liu XT; Wang YQ; Cai DY
World J Gastroenterol; 2013 Sep; 19(36):6069-76. PubMed ID: 24106408
[TBL] [Abstract][Full Text] [Related]
39. Role of gap junctions modulating hepatic vascular tone in cirrhosis.
Hernández-Guerra M; González-Méndez Y; de Ganzo ZA; Salido E; García-Pagán JC; Abrante B; Malagón AM; Bosch J; Quintero E
Liver Int; 2014 Jul; 34(6):859-68. PubMed ID: 24350605
[TBL] [Abstract][Full Text] [Related]
40. Augmented portal flow in the isolated perfused cirrhotic rat liver: a haemodynamic and morphological study.
Cardoso JE; Calmus Y; Legendre C; Cherruau B; Jeyaraj PR; Crougneau S; Habib N; Houssin D
Clin Sci (Lond); 1993 Feb; 84(2):185-92. PubMed ID: 8382584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
